Norden Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.76M Buy
36,348
+749
+2% +$66.9K 0.31% 67
2026
Q1
$2.56M Buy
35,599
+454
+1% +$35K 0.25% 83
2025
Q4
$2.79M Buy
35,145
+330
+0.9% +$26K 0.27% 69
2025
Q3
$2.62M Sell
34,815
-299
-0.9% -$20.5K 0.27% 74
2025
Q2
$2.42M Buy
35,114
+1,010
+3% +$66.2K 0.26% 79
2025
Q1
$2.31M Buy
34,104
+983
+3% +$58.8K 0.27% 74
2024
Q4
$1.49M Sell
33,121
-411
-1% -$23.1K 0.17% 122
2024
Q3
$2.11M Buy
33,532
+22,039
+192% +$1.29M 0.25% 93
2024
Q2
$679K Buy
11,493
+4,663
+68% +$292K 0.14% 164
2024
Q1
$545K Buy
6,830
+660
+11% +$50.4K 0.11% 212
2023
Q4
$487K Sell
6,170
-673
-10% -$47.9K 0.08% 147
2023
Q3
$478K Buy
+6,843
New +$485K 0.16% 132

Other funds holding CVS

Norden Group's CVS Position: Q2 2026 in Review

Norden Group increased its CVS Health (CVS) stake by 2.1% in Q2 2026, buying an estimated $66.9K and bringing the position to 36,348 shares worth $3.76M. The position accounts for 0.31% of the portfolio, ranked #67.

Norden Group first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Norden Group held 36,348 shares of CVS Health worth $3.76M as of Q2 2026.
  • Norden Group bought 749 CVS Health shares in Q2 2026, an estimated $66.9K.
  • CVS Health made up 0.31% of Norden Group's portfolio in Q2 2026, its #67 holding.
  • Norden Group first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.